Category: TeleflexSyndicate content

CeQur names medtech veteran as new CEO | Medtech personnel moves for the week of Apr. 14, 2014

April 16, 2014 by MassDevice

Here's a look at some of the top personnel stories for medical device companies this week.

CeQur gets new CEO from Becton Dickinson | Personnel Moves

April 11, 2014 by Arezu Sarvestani

fired/hired

Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.

CeQur gets new CEO from Becton Dickinson | Personnel Moves

April 11, 2014 by Arezu Sarvestani

CeQur gives Douglas Lawrence the keys to the corner office, taking him from the insulin injection business at Becton Dickinson.

fired/hired

Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.

Lawrence has spent more than 25 years in the medical device industry, most recently as vice president of the insulin injection business at Becton, Dickinson's (NYSE:BDX) diabetes arm.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Teleflex: We're having trouble with the Semprus technology

February 25, 2014 by Brad Perriello

Teleflex says it's having trouble developing the medical device coating technology it acquired along with Semprus BioSciences for up to $80 million.

Teleflex: We're having trouble with the Semprus technology

Teleflex (NYSE:TFX) is having trouble developing the anti-microbial coating technology it acquired along with Semprus BioSciences for up to $80 million in 2012, according to a regulatory filing.

Teleflex Medical initiates Class I tracheal tube recall

February 13, 2014 by Chris Walker

Teleflex Medical's recall of the ISIS HVT tracheal tube is labelled by the FDA as Class I, denoting the risk of serious injury or death.

Teleflex Medical is recalling its tracheal tube

The voluntary recall by Teleflex Medical (NYSE:TFX) of its Isis HVT tracheal tube was given Class I status by the FDA, denoting the risk of serious injury or death.

Teleflex said it issued the recall because of the potential for the tracheal tube to kink and deprive patients of ventilation, possibly leading to hypoxic injury or anoxia.

Teleflex dips on lowered 2013 sales outlook

December 17, 2013 by Brad Perriello

Teleflex cuts its constant-currency sales outlook for 2013, sending shares down slightly on Wall Street.

Teleflex dips on lowered 2013 sales outlook

Teleflex (NYSE: TFX) shares slipped a bit this morning after the medtech company said it's lowering its constant-currency sales outlook for this year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Teleflex closes $263M Vidacare buy

December 3, 2013 by Arezu Sarvestani

Teleflex ties a ribbon around its $263 million acquisition of inside-the-bone access devices maker Vidacare Corp.

Teleflex closes $263M Vidacare buy

Pennsylvania technology giant Teleflex (NYSE:TFX) put the finishing touches on a $263 million acquisition of Vidacare Corp., a company that makes inside-the-bone access devices.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

GPOs: Novation, Teleflex ink new deal

November 14, 2013 by Chris Walker

Group purchasing organization Novation awards a supply deal to Teleflex for its Arrow intra-aortic balloon catheters and pumps.

GPOs: Novation, Teleflex ink new deal

Group purchasing organization Novation inked a new contract with medical device company Teleflex (NYSE:TFX).

The deal calls for the Limerick, Pa.-based medical device company to provide its complete line of Arrow intra-aortic balloon catheters and pumps. The agreement is slated to begin Jan. 1, 2014.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp